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Abstract
 The objective of this study was to analyze the association of abnormal blood metabolite 
levels (prepartum and postpartum non-esterified fatty acids (NEFAs), β-hydroxybutyrate (BHB), 
and calcium) and periparturient diseases (clinical ketosis, mastitis, displaced abomasum, retained 
placenta, metritis, lameness and periparturient paresis) with rate of weight loss and milk yield 
during a cow’s first thirty days in milk.  A total of 105 Holstein cows from three dairy farms in 
central New York State were analyzed in the study.  Blood samples, back fat measurements, body 
condition scores, lameness assessments, and records for body weight, milk yield, and disease 
occurrence were collected at different time points beginning approximately a week before 
parturition until thirty days in milk.  Back fat and body condition scores were not correlated with 
each other and were not included in the final analysis.  The associations between the interaction 
of each blood metabolite with disease and change in body weight and milk yield were stratified 
by parity and evaluated with the MIXED procedure in statistical software.  All cows which 
developed disease experienced a higher rate of weight loss and produced less milk than their 
healthy herd mates.  Each parity group had a different indicator metabolite for predicting faster 
weight loss (parity 1 = prepartum NEFA, parity 2 = BHB, parity 3 = postpartum NEFA), but 
calcium was not a reliable indicator for any group.  Elevated prepartum NEFA and BHB levels 
were associated with reduced milk production for cows of parity > 2, while blood metabolites 
were only useful for heifers which concurrently developed disease.  Through the use of these 
tests, farmers can intervene early to optimize animal health and economic return.
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Introduction
 The contemporary dairy industry is of considerable interest to the economic health of the 
United States, generating an estimated $140 billion in economic output (Guduru, 2012) from 200 
billion pounds of milk (Progressive Dairyman, 2013) made by over nine million cows (USDA/
National Agricultural Statistics Service, 2007).  New York State ranks fourth nationally in total 
milk production, with about 610,000 cows and an average herd size of 118 (USDA, 2012).  With 
this many animals in each herd, efficient management practices focus on groups; for example, 
cows are usually fed and housed by pen instead of by cow.  As such, veterinary recommendations 
are focused on group or herd management.  
 To maximize economic return, individual productivity is still important; each cow 
represents a potential 22,000 pounds of milk yield per year (USDA, 2012).  A successful 
lactation, characterized by high milk yield with minimal disease development, is essential to the 
economic sustainability of a dairy farmer. Therefore, identifying cows with a higher risk of poor 
economic return is helpful for balancing a producer’s budget.  
 The objective of this study was to analyze the association of abnormal blood metabolite 
levels and periparturient diseases with rate of weight loss and milk yield during a cow’s first 
thirty days in milk.  High risk individuals are defined as those with circumstances that reduce 
their milk yield below that of their average healthy herd mate for the given lactation period.  This 
classification also applies to cows which experience a more precipitous drop in body weight 
during the given lactation period and may be subject to a longer-term compromise in milk 
production and health outcomes.  
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 The transition period was chosen as the time bracket of interest in analyzing the cows in 
this study.  This period is characterized by a radical physical transition from gestation to 
lactation, and cows are challenged to adjusting to these dynamic physiological, metabolic, and 
nutritional shifts (Bauman and Currie, 1980).  Cows which have difficulty in making a successful 
transition are subject to experiencing negative energy balance and hypocalcemia.  According to 
Goff and Horst (1997), the transition period is also the time during which dairy cows experience 
the highest incidence of periparturient diseases, including but not limited to clinical ketosis, 
mastitis, displaced abomasum, retained placenta, metritis, lameness and hypocalcemia, which 
can be subdivided into sub-clinical and clinical presentation of periparturient paresis, known 
commonly as milk fever.  
 In this study, the change in body weight and milk yield over the cow’s first thirty days in 
milk (DIM) were evaluated, with day zero = the calving date.  The levels of non-esterified fatty 
acids (NEFAs) and β-hydroxybutyrate (BHB) in the cow’s blood were measured as metabolic 
indicators.  Serum calcium was used as an indicator of calcium homeostasis.   The associations 
among these indicators, along with disease incidence, were analyzed with change in body weight 
and milk yield during the first 30 DIM as the outcomes.  A BHB test strip currently costs $1.30 
(mwivet.com), a local NEFA test costs $11.00 and serum calcium costs $8.00 (New York Animal 
Health Diagnostic Center).
 The experimental goal is to compare the reliability of these tests with their cost to 
recommend to dairy farmers which blood metabolites are the most useful indicators of milk yield 
and body weight change during the first 30 DIM and when those readings should be collected.
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Literature Review
! The transition period between late gestation and early lactation, also known as the 
periparturient period, brackets the three weeks prior and following parturition in the dairy cow 
(Goff and Horst, 1997).  This time is characterized by drastic physiological, metabolic, and 
nutritional changes to the cow’s body as it adapts from carrying a fetus to producing copious 
amounts of milk.  These shifts are the coordinated result of hormones and feedback mechanisms 
working to balance energy needs and maintain calcium homeostasis, described by Bauman and 
Currie (1980).  During the transition period, these homeorhetic adaptations meet the challenges 
of doubling energy requirements (Bell, 1995) and calcium needs (Hansard et al., 1957; Martz et 
al., 1990) with a concurrent lag in dry matter intake (Drackley et al., 2001; Melendez and Risco, 
2005).  
 In light of this, it is not surprising that most of the metabolic diseases of dairy cows occur 
during the first few weeks of lactation before peak milk yield (Goff and Horst, 1997; Ingvartsen, 
2006).  In addition to the immediate impact these disorders have on the cow’s welfare, milk yield 
and reproductive performance for the current lactation, they can also burden the dairy producer 
with increased treatment costs and culling rates (Risco and Melendez, 2002).  This is 
compounded by the fact that many of these calving-related diseases are associated with one 
another.  For example, Curtis et al. (1983) reports that dairy cattle that develop milk fever are 
eight times more likely to develop mastitis during the same lactation, while LeBlanc et al. (2005) 
indicates that cows with sub-clinical ketosis are eight times more likely to develop a displaced 
abomasum.  Melendez and Risco (2005) report on a large number of associations among 
periparturient diseases, linking periparturient paresis with retained placenta (odds ratio=2.0) and 
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metritis (=1.6) as well as clinical ketosis with periparturient paresis (=23.6) and displaced 
abomasum (=53.5).  Both Duffield (2000) and Mulligan and Doherty (2008) further discuss the 
linked etiology of these periparturient diseases with one another and with the metabolic shifts the 
cow is experiencing at this time.
Negative Energy Balance
 When a cow’s metabolic output, in the forms of tissue maintenance, activity, and 
lactation, exceed the caloric intake from its feed, it is said to be in negative energy balance 
(Figure 1).  This causes it to mobilize body reserves to compensate for the energy deficit between 
dry matter intake and the energy output for milk production (Bauman and Currie, 1980).  
Negative energy balance reaches its maximum one to two weeks after the onset of lactation 
(Butler and Smith, 1989), and disposes the cow to a host of metabolic disorders such as fatty 
liver and ketosis (Doherty, 2002; Bertics et al., 1992), displaced abomasum (Duffield et al. 2009; 
LeBlanc et al., 2005), retained placenta (Cameron, 1998), and immunosuppression (Goff, 2008). 
Figure 1.  Energy balance.  A cow’s energy status represents the dynamic balance between 
caloric inputs and outputs.  If a cow expends more energy than it can obtain from its feed, this 
equilibrium “tips” to the right and it is considered to be in a state of negative energy balance.
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Etiology and Impact of Negative Energy Balance
 The cow’s glucose requirements spike from 1 kg/day during late gestation to over 2.5 kg/
day during the postpartum transition period (Reynolds et al., 2003).  Because little glucose is 
absorbed from the gut (Otchere, 1974), two key adaptations to this accelerated energy demand 
are mobilization of triglycerides in adipose tissue to non-esterified fatty acids (McNamara, 1991) 
and hepatic oxidation of circulating NEFAs to β-hydroxybutyrate (Emery et al., 1992).  This, in 
addition to an increase in gluconeogenesis from amino acid, lactate, and glycerol precursors 
provides the necessary energy to support the mammary gland (Drackley, 1999; Herdt, 2000; 
Reynolds, 2003) for the production of lactose (Bruss, 2008; Figure 2).  
Figure 2.  Blood metabolites and the biology of energy balance.  The energy necessary for 
lactation comes from a variety of sources, as elaborated upon by Bruss (2008) and Drackley et al. 
(2001).
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 If the production of NEFAs and BHBs exceed the ability of the mammary gland to 
metabolize them for energy, they accumulate in the bloodstream (Adewuyi, 2005).  Clinically 
ketotic cows experience reduced dry matter intake, a loss in milk yield, and demonstrate 
symptoms of nervous system involvement such as staggering, lack of coordination, and blindness 
(Adewuyi et al., 2005).  Even sub-clinical levels of NEFAs and BHB are a detriment to the cow 
because they make it almost tenfold more likely to develop clinical ketosis (Suthar et al., 2013), 
as well as predisposing it to developing a displaced abomasum, mastitis, metritis, and lameness 
(Lean, 2011).  Furthermore, both severity and duration of high BHB levels can interfere with 
reproductive success (Walsh et al., 2007). 
 These effects are most pronounced immediately after calving, when blood NEFA and 
BHB levels are highest (Weber et al., 2013).  Ospina et al. (2010a) determined critical thresholds 
for blood NEFA and BHB levels associated with the onset of periparturient diseases up to 120 
DIM.   McArt et al. (2012) and Gröhn et al. (1998) reported that cows above the > 1.2 mmol/L 
threshold for BHB concentrations were more likely to be culled from the herd, costing dairy 
producers about $145/case (Melendez and Risco, 2005).  
Quantifying Energy Balance
 While the relationship between these diagnostic parameters and milk yield has been well-
studied (Dohoo and Martin, 1984; Duffield et al., 2009; Lean, 2011; Ospina et al., 2010b and 
2010c), their association with change in body condition over time is not well understood.  This 
can be studied objectively using changes in body weight over time, which according to 
Kohiruimaki et al. (2006) is a reliable indicator for the anticipated incidence in periparturient 
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disease. The drawback is that this does not representatively account for the impact a given 
weight loss value has for cows of different starting weights.  
 Another option is to use the body condition scoring system developed by Edmondson et 
al. (1989), which is a subjective assessment of the cow’s fat reserves through visual assessment 
of its lipid stores relative to its body frame (Figure 3).  Studies link body condition score to milk 
yield in dairy cows up to 120 DIM (Domecq et al., 1997).  This has the inherent disadvantage of 
different score assignments by different individuals, although observer agreement within a 
quarter point standard deviation was about 90% in a survey by Ferguson et al. (1994).  Its utility 
in accurately predicting body weight when hip height and hip width are provided in a 
mathematical model was supported by Enevoldsen and Kristenen (1997), and Waltner et al. 
(1994) testifies that combining body condition score and body weight reliably predicts body fat 
content in lactating dairy cows.  
Hook Pin 
Thurl 
Figure 3.  Determination of body condition score based on visual assessment.  Body condition 
scoring is an objective assessment of a cow’s energy status by evaluating the degree of adiposity 
on the cow relative to its body frame, using anatomical landmarks such as the hook, pin, and 
thurl.  This image was modified from BCS by Deutscher Holstein Verband e.V. [Internet]  http://
www.holstein-dhv.de/exterieur.html.  Accessed 30 March 2013.
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 A final criterion is the use of diagnostic ultrasound in screening the back fat thickness of 
these cows, which can serve as an objective test of the degree of adipose tissue mobilization at 
the level of herd screening (Schröder and Staufenbiel, 2006).  
 Calcium Homeostasis
 Maintaining constant blood calcium levels, at the narrow range of eight to ten mg/dL in 
dairy cows (Goff et al., 1996) is critical to neuromuscular excitability, blood clotting, and 
endocrine function (Griffin and Ojeda, 1996).  According to DeGaris and Lean (2008), the 
lactating dairy cow can lose up to 50 grams of calcium to mammary production on a daily basis, 
which equates a four- to five-fold increase of plasma clearance relative to the rate at parturition 
(Oetzel and Goff, 1998).  The cow’s options for meeting these calcium needs are limited to 
increasing intestinal absorption of dietary calcium, and mobilizing calcium from skeletal reserves 
following parathyroid hormone signaling (DeGaris and Lean, 2008; Goff, 2008, Figure 4).  
Figure 4.  The biology of calcium homeostasis.  To meet the calcium demands imposed by 
lactation while maintaining systemic levels for homeostasis, the dairy cow obtains calcium from 
its feed and skeletal reserves, as discussed by DeGaris and Lean (2008) and Goff (2008).
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Etiology and Impact of Hypocalcemia
 When the cow is unable to restore homeostatic blood calcium levels and they drop below 
5.6 mg/dL (Degaris and Lean, 2008), it experiences the neuromuscular dysfunction typical to 
milk fever, known clinically as periparturient paresis (El-Samad et al., 2002; Horst et al., 1997).  
Upon manifestation of these symptoms, intravenous calcium is therapeutically administered to 
sustain the cow until its intestinal absorption and bone reabsorption can adapt, without which up 
to 70% of clinically affected cattle can be culled (Horst et al., 1997).  Between six and eight mg/
dL, the cow still experiences reduced feed intake, poor rumen motility, reduced milk yield, and 
the increased incidence of disease (Chapinal et. al, 2011; Horst et al., 2003; Ingvartsen, 2006; 
Klerx and Smolders, 1997).  This could be due in part to sub-clinical hypocalcemia handicapping 
the ability of neutrophils to phagocytize pathogens (Martinez et al., 2012), decreasing immune 
cell sensitivity to pathogenic stimuli (Kimura et al., 2006), and exacerbating periparturient 
immunosuppression with lowered plasma cortisol levels (Goff and Horst, 1997), opening the 
door for infectious diseases such as mastitis and metritis.  
 Low serum calcium concentrations are also associated with negative energy balance 
(Reinhardt et al., 2011).  As Daniel (1983) described, serum calcium concentrations below 5 mg/
dL can reduce abomasal motility by 70% and the strength of contraction up to 50%, which 
inhibits rumen function.  Consequently, dry matter intake decreases, with a parallel rise in the 
severity of negative energy balance.  Grummer (1996) brought this process full-circle in 
emphasizing that increasing blood NEFA concentrations can further suppress appetite.
 Reinhardt et al. (2011) determined the annual incidence of periparturient paresis in the 
United States to be around 1% for heifers and 6% for second and greater lactation dairy cows, 
while Horst et al. (2003) reports that sub-clinical hypocalcemia can affect up to 50% of older 
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cows. Milk fever poses a notable economic burden to dairy producers because of reduced milk 
yield (Østergaard and Gröhn, 1999), costly intervention therapies (Kossaibati and Esslemont, 
1997), and associations with other diseases (Curtis et al., 1983; Fleischer et al., 2001; 
Thirunavukkarasu et al., 2010).  
 Common Diseases of the Periparturient Period
 Periparturient diseases in dairy cattle often arise as a consequence of accelerated energy 
and calcium demands during the transition period.  While the term was traditionally applied in 
reference to metabolic disorders, its definition has since expanded to include other diseases that 
commonly occur around calving, such as retained placenta, displaced abomasum, and mastitis 
(Mulligan and Doherty, 2008).  While their clinical manifestations were not the focus of this 
study, the substantial economic consequences this poses to the dairy producer (Kelton et al., 
1998; Melendez and Risco, 2005) justifies evaluating them in terms of making practical 
recommendations to the dairy farmer.
Displaced abomasum
 Displaced abomasum is clinically defined as the abomasum filling with gas and rising up 
along the side of the rumen, causing a loss in appetite and the production of a high-pitched 
“pinging” sound upon percussion of the abdominal wall (Kelton et al., 1998).  Its incidence in 
dairy herds is between 1.7% and 3.3% (Ingvartsen, 2006).  Melenez and Risco (2005) quantified 
the economic losses due to displaced abomasum to be about $340 per case, and between 250 and 
2000 kg of milk per lactation.
 Risk factors for developing a displaced abomasum include prepartum negative energy 
balance indicated by high serum NEFA and BHB concentrations, consuming high energy feeds, 
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calving in the winter, birthing twins, development of retained placenta and/or metritis, (Cameron 
et al., 1998; LeBlanc et al., 2005).  The role of hypocalcemia in the manifestation of displaced 
abomasum is currently unclear (Curtis et al., 1983 and Leblanc et al., 2005). Low parity and 
having a body condition score above 4.0 been implicated as a risk factor for displaced abomasum 
development (Cameron et al., 1998 and Shirley, 1994, respectively), although their utility as 
predictors is still questioned (Dohoo and Martin, 1984; Leblanc et al., 2005). What is clear is that 
a reduction in abomasal motility is a key step towards displaced abomasum development.  
Ketosis is often associated with a low dry matter intake, causing reduced fluid volume and 
limiting forestomach motility, the effects of which are passed on to the abomasum (Cameron et 
al., 1998).
Lameness
 According to the visual locomotion scoring protocol recommended by Bicalho et al. 
(2007), a cow is clinically lame if its ambulation score is > 3 during the first 70 DIM.  This is 
often accompanied by distinct favoritism in weight-bearing limbs.  It affects 7% to 14% of dairy 
cattle (Ingvartsen, 2006) and mostly occurs early in lactation even though most physical injuries 
to the hoof occur prepartum (Wilde, 2006).  Lameness exacerbates the metabolic impacts of 
negative energy balance by reducing the cow’s willingness to regularly feed, thereby lowering 
dry matter intake.  Economic losses are a product of reduced milk yield (Warnick et al., 2001) 
and increased risk of culling (Esslemont and Kossaibati, 1997; Sprecher et al., 1997).  Lameness 
causes dairy producers about $300 per case, according to Melendez and Risco (2005).  Risk 
factors for the development of lameness include laminitis, negative energy balance, and a loss in 
body condition score (Collard et al., 2000; Wells et al., 1993).
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Mastitis
 Kelton et al. (2008) characterized clinical mastitis as an infection involving the secretion 
of visually abnormal milk (watery or containing clots of flakes) from one or more quarters, often 
accompanied by inflammation and edema of the udder.  Rajala-Schultz et al. (1999) reports that 
milk losses from mastitis throughout a lactation can tally between 100 and 500 kgs of milk, and 
that cows affected by mastitis did not recover their premastitis milk yield throughout the course 
of the study.  The incidence of clinical mastitis is typically between 14% and 17% (Ingvartsen, 
2006) but it can affect up to 50% of a dairy herd (Melendez and Risco, 2005).  Risk factors for 
the development of mastitis include being a Holstein-Fresian cow, high milk yield, 
hypocalcemia, and negative energy balance (Berry et al., 2007; Curtis et al., 1983; Ingvartsen et 
al., 2003; Mulligan and Doherty, 2008).  Berry et al. (2007) reported a negative association 
between body weight and masitis in first parity cows, but this relationship was reversed for 
second lactation and greater cows.
Retained Placenta and Metritis
 Retained placenta is defined as the failure of fetal membrane expulsion during the final 
stage of parturition, identified by the presence of fetal membranes at the vulva or in the uterus or 
vagina more than 24 hours after the first postpartum observation (Kelton et al., 1998).  This 
predisposes the cow to developing metritis, the diagnosis of which requires abnormal cervical 
discharge, vaginal discharge or both or uterine content often accompanied by an elevated 
temperature and reduced dry matter intake (Kelton et al., 1998; Mulligan and Doherty, 2008).  
Retained placenta is seen in 7% to 9% of dairy cows, while 10% to 13% experience metritis 
(Ingvartsen, 2006).  These disorders take an economic impact to the farmer in terms of 
treatments for infection, greater number of days from calving to conception, and culling 
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(Melendez and Risco, 2005). These monetary losses from metritis total about $106 per lactation 
in 1986 (Bartlett et al.), while the price tag of retained placenta was set at about $285 in 2005 
(Melendez and Risco).
 Cows on their third lactation or greater experience retained placenta about twice as often 
as heifers and second lactation cows (Bartlett et al., 1986).  Other risk factors include high 
prepartum NEFA levels and hypocalcemia (Curtis et al., 1983; Dubuc et al., 2010; Wilde, 2006).  
Forty-four percent of cows that had retained placenta develop metritis over during their current 
lactation, versus sixteen percent of cows which were not affected with retained placenta but 
developed metritis.  This causal relationship has been investigated in other studies as well 
(Dohoo and Martin, 1984; Dubuc et al., 2010; Fleischer et al., 2001).
Current Shortcomings
 Although the associations among negative energy balance, calcium homeostasis, and both 
disease and milk production in the transition period have been comprehensively studied, some 
deficiencies in knowledge persist.  Few studies simultaneously collected information on levels of 
NEFAs, BHB, and calcium, daily body weight and daily milk production for the purposes of 
evaluating a dairy cow’s whole health status during the early lactation period.  
 Collard et al. (2000) evaluated body weight on a weekly, monthly, or every 100 day-basis 
and found that it is an important indicator of future lactation success and disease risk.  However, 
body weight cannot be measured easily nor frequently on conventional farms with limited weight 
detection capabilities.  With the advent of automatic milking systems that employ built-in weight 
scales, body weight can be regularly monitored as an index of health. While previous studies 
have investigated the links between these metabolic indicators and milk yield, (Chapinal et al., 
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2012; Jawor et al., 2012; Østergaard and Larsen, 2000), their associations with changes in body 
weight throughout lactation have not been as thoroughly explored.  In a recent study, Weber et al. 
(2013) reported that cows with the highest NEFA values demonstrated the greatest loss in body 
weight, while those with moderate NEFA levels lost more back fat.  However, this study did not 
examine the relationship between blood BHB or serum calcium levels and body weight.  The 
current study aimed to address this lack of information.
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Materials and Methods
Study Population
 Holstein cows, a breed of domestic cattle Bos taurus, were studied from three 
conveniently-selected commercial farms in central New York State.  Inclusion criteria for these 
herds were as follows: 1) >100 milking cows, 2) free-stall housing, 3) fed a total mixed ration 
formulated to meet or exceed the National Research Council nutrient requirements for lactating 
Holsteins according to farm conditions, and 4) use of automatic milking systems (Astronaut A3 
and A4, Lely Industries N.V, Rotterdam, The Netherlands).  All farms consented to participate, 
and the study was approved by the Institutional Animal Care and Use Committee.
 From these herds, a convenience sample of heifers and cows calving in between June 
11th and August 18th of 2012 were enrolled in the study.  The goal was to enroll 100 cows and 
follow them until 30 DIM in order to find a minimum of 1.5 kilograms of difference in daily 
milk production between groups, with a 3 kilogram standard deviation, 95% confidence interval 
and power of 80%.  Both nulliparous heifers and multiparous cows were enrolled in the study.  
Enrollment in the study occurred once weekly between three and 10 days prior to the expected 
calving date predicted by each herd’s farm management software.  
 
Data Collection
 During enrollment, blood was collected from the coccygeal vessels from each cow 
expected to freshen in the following week into a 10-mL non-additive evacuated glass tube using 
a 20-gauge, 2.54-cm blood collection needle.  The BHB concentrations were evaluated 
immediately cow-side using the Precision Xtra meter (Abbott Laboratories, Abbott Park, IL; 
Iwersen et al., 2009).  Within 30 minutes of collection, all blood samples were centrifuged for 15 
minutes at 2,000xG.  Following this, serum was harvested and stored in ice for transportation to 
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the lab, where it was frozen at -20°C according to the recommendations of Stokol et al. (2005).  
All serum samples were then sent to New York Animal Health Diagnostic Center (Ithaca, NY) 
for total calcium concentration (Roche Diagnostic reagents) and serum NEFA concentration 
analysis (NEFA-C, Wako Chemicals USA Inc., Richmond, VA).  In addition to blood sampling, 
enrolled cows also had their body condition score determined on a 5-point scale (1=emaciated, 
5=obese, scored in 0.25-point intervals) using the method described by Ferguson et al. in 1994 
(Figure 3). Lameness was also assessed visually on a 5-point scale (1=normal; 3=moderately 
lame, cow clearly favored one or more limbs; 5=severely lame, non-weight bearing, scored on 
whole number intervals) according to the standards set by Bicalho et al. (2007; Figure 5).  
1
5
Figure 5.  Determination of lameness score based on visual assessment.  Scoring is performed by  
veterinarians and herdsmen alike as part of a routine physical exam.  This image was modified 
from Locomotion Scoring of Dairy Cattle by Dr. Steven Berry.  University of Wisconsin-
Madison and Zinpro Corporation.  Published 5 March 2005. [Internet] http://
www.vetmed.wisc.edu/dms/fapm/fapmtools/6lame/New5point_locomotionscoreguide.pdf.  
Accessed 30 March 2013.
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 Back fat thickness was evaluated using an Ibex Pro portable ultrasound machine with an 
8.5MHz 66-mm linear probe (E.I. Medical Imaging, Loveland, CO) to the nearest millimeter in 
the manner described by Schröder and Staufenbiel in (2006; Figure 6). 
Figure 6.  Determination of back fat thickness using a portable ultrasound machine.  Back fat 
thickness is measured to the nearest millimeter using a portable ultrasound machine with a linear 
probe.  According to the method set by Schröder and Staufenbiel in 2006, the superficial 
termination is the skin and the deep termination is the fascia trunci profunda.
 After each cow was enrolled, blood samples were collected multiple times: at one, two, 
three, and five days postpartum, then weekly until 30 DIM.  Serum NEFA was evaluated one 
week prepartum and at five DIM; whole blood BHB was evaluated one week prepartum, at three 
and five DIM, and weekly until 30 DIM; serum total calcium was evaluated one week 
prepartum, and at one, three, and five DIM; body condition score and back fat were evaluated 
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one week prepartum, at five DIM, and weekly until 30 DIM, and lameness was evaluated one 
week prepartum and weekly until 30 DIM (Table 1).  Back fat and body condition score were 
evaluated at day five, then weekly until 30 DIM along with lameness scores.  Daily body weight 
and daily milk weight for each cow was collected by the Lely T4C management system (Lely 
Industries N.V/, Rotterdam, The Netherlands).
-1 Week +1 Day +2 Days +3 Days +5 Days Weekly until 30 DIM
NEFA × ×
BHB × × × ×
Total Calcium × × × × ×
Back Fat × × ×
Body Condition 
Score × × ×
Lameness × ×
Table 1.  A complete sample collection schedule of blood chemistry, body condition score, back 
fat, and lameness.  All days listed are relative to calving date (0 DIM).
 Farm personnel also documented the occurrence of clinical ketosis, displaced abomasum, 
lameness, clinical mastitis, retained placenta, and metritis on either Dairy Comp 305 (Valley Ag. 
Software, 2009) for two farms, or paper records for the third farm.  Standard disease definitions 
were discussed with the workers at each farm at the start of the study, however the diagnosis and 
care of affected animals was delivered according to farm protocols defined by the veterinarian 
responsible for the herd.
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Statistical Analysis
 The daily body weight and daily milk weight information was imported from the Lely 
T4C management system (Lely Industries N.V/, Rotterdam, The Netherlands) into Excel 
(Microsoft, v. 97-2003).  The slope of the change in body weight for each animal during the first 
30 DIM was estimated with simple linear regression with a line of best fit (JMP statistical 
package, version 9 SAS Inst. Inc., Cary, NC, 2011).  The sum of milk production over the first 30 
DIM was also evaluated.  For cows missing only one or two data points, missing values for daily 
milk weights were filled-in using the linear regression line of best fit equation determined by the 
same JMP procedure used for body weight change.  
Statistical Summary
 Descriptive statistics were generated with the FREQ and MEANS procedures of SAS 
(version 9.3 SAS Inst. Inc., Cary, NC).   This was used to characterize the data.  The CORR 
procedure, specifically Pearson’s correlation coefficient, was used to evaluate the correlation 
between back fat and body condition score.  The MIXED procedure was used to evaluate the 
association between each blood metabolite with change in body weight and milk production 
during the first 30 DIM.  These univariable analyses were used to determine which sample 
among metabolites that were measured on more than one day (BHB and calcium) would be used 
in the final analyses.  The predictors included in the final analyses for the change in body weight 
over time and milk production during the first 30 DIM were parity group, disease development, 
dichotomized levels of pre- and post-partum NEFA, BHB, and calcium with herd treated as a 
random effect.
Based on information from previous reports which associate certain concentrations of 
calcium, NEFA, and BHB with negative downstream outcomes (Ospina et al., 2010a; Reinhardt 
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et al., 2011), the total calcium concentrations were dichotomized at > 6.0 mg/dL to 8.0 mg/dL to 
evaluate the effect of sub-clinical hypocalcemia, pre-partum NEFA was dichotomized at ≥ 0.3 
mEq/L; post-partum NEFA ≥ 0.7 mEq/L, and BHB at ≥ 1.2 mmol/L.
Stratification by Parity
 The difference in mean change in body weight and total milk production in the first 30 
DIM by parity group (parity =1, parity =2, parity ≥2, and parity ≥3) was evaluated using the T-
test procedure in SAS.  Analyses were stratified by parity if there was a significant difference (p 
< 0.05) between parity groups in milk production or body weight.  Three lactation groups were 
evaluated separately in the body weight model: parity =1, parity =2, and parity ≥ 3. Two lactation 
groups were evaluated separately in the milk production model: parity =1 and parity ≥ 2.  
Metabolite Analyses, Disease, and Interactions as Covariates
 The effect of these metabolites on body weight change and total milk yield over the first 
30 DIM were each evaluated in separate univariable models.  Calcium and BHB results were 
screened for the best predictive sample, and prepartum and postpartum NEFA measurements 
were treated as unique predictors.  While controlling for the effect of other metabolite samples 
collected on different days, the measurement that resulted in the smallest p-value and had the 
largest estimate difference from a baseline of zero was defined as the best predictive sample and 
kept in the final model.  Because the effect of the various indicator metabolites on body weight 
change and milk yield outcomes was different (p < 0.01) based on the presence or absence of 
disease (clinical ketosis, displaced abomasum, lameness, clinical mastitis, retained placenta, and/
or metritis), the interaction between each indicator metabolite and disease was forced into the 
final model.
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The final model consisted of the best predictive metabolite, the effect of disease 
occurrence, and the interaction between disease and the metabolite with herd being treated as a 
random effect.  The occurrence of any disease was categorized as 1 if the animal developed any 
of the following diseases: clinical ketosis, displaced abomasum, lameness, mastitis, retained 
placenta, or metritis during the first 30 DIM. The MIXED procedure was used to evaluate the 
association between interactions of blood metabolites and disease.  The Least Squares Means 
estimates and p-values were reported for the interactions and they evaluate whether the 
combination estimate is different from zero.  However, these combination estimates were also 
compared to each other using the DIFF statement of the Least Squares Means model in SAS, and 
superscripts denoting a statistical difference of p > 0.05 were also noted. 
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Results
Study Population Descriptive Results
A total of 114 cows were enrolled in the study, with nine cows excluded from data 
analysis due to removal from the herd resulting in fewer than 30 DIM of body weight and milk 
yield information.  Of the nine cows excluded, three died (one listeria, one back injury, and one 
undefined), two were culled, and four had an incomplete data set due to technical difficulties 
with the automatic milking systems, bringing the final sample population for this study to 105 
cows.  Overall, these cows averaged 34 - 36.1 kg of milk production per day, and 1023 - 1083 kg 
of milk production total during the first 30 DIM.  
 Descriptive frequencies of the study population are presented in Table 2, and are 
organized by parity, blood metabolite groups and whether or not they had disease (clinical 
ketosis, displaced abomasum, lameness, clinical mastitis, retained placenta, and metritis).  The 
frequency of each disease condition by parity is shown in Figures 7 and 8.  Back fat thickness 
was weakly correlated with body condition score: R2 for weeks one through three was 0.3 and 
for week four was 0.7.
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Parity High NEFAa High BHBb
Sub-clinical 
[+ Clinical Hypocalcemia] c Disease 
d Total in Each 
Parity
1st 19 7 6 16 30
2nd 18 21 16 16 28
3rd+ 22 29 32 [+3] 50 42
Total 59 57 54 [+3] 82
105
Percent Total 56.2% 54.3% 51.4% [2.9%] 78.1%
Table 2.  Number of cows grouped by parity, dichotomized by blood metabolite groups, and 
dichotomized by disease occurrence in 105 Holstein cows within the first 30 DIM.
a   A prepartum NEFA of  > 0.3 mEq/dL and/or a postpartum NEFA of > 0.7 mEq/dL. 
b   Any BHB reading > 1.2 mmol/L.
c   Any calcium reading of 6 – 8 mg/dL (sub-clinical) or < 6 mg/dL (clinical).
d   Diseases include clinical ketosis, displaced abomasum, lameness, clinical mastitis, retained 
placenta, and/or metritis.  Note that each condition is not mutually exclusive.
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Figure 7.  The frequency and distribution of disease conditions (clinical ketosis, displaced 
abomasum, lameness, clinical mastitis, retained placenta, and/or metritis) among the study 
population of 105 Holstein cows within the first 30 DIM, separated by parity.
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Figure 8.  The percent distribution of disease conditions (clinical ketosis, displaced abomasum, 
lameness, clinical mastitis, retained placenta, and/or metritis) among the study population of 105 
Holstein cows within the first 30 DIM, separated by parity.
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Associations: Rate of Body Weight Change
All cows had a negative change in body weight over the course of the study (i.e., the first 
30 DIM).  The analyses for change in body weight were stratified by parity  (parity = 1, parity = 
2, and parity ≥ 3) because the change in body weight was different among these groups (p < 
0.01), as shown in Figure 9.  Tables 3A-3D show the effect on body weight change based on the 
interaction between normal or abnormal values for each indicator metabolite and the presence or 
absence of disease: prepartum NEFA (3A), postpartum NEFA (3B), BHB (3C) and calcium (3D).  
When an interaction term was included, the effect of only the blood metabolite or disease 
occurrence could not be evaluated individually because the result depends on the values of both 
terms in the interaction.  Therefore, the interaction estimates and p-values are reported.
A more precipitous weight loss during the first 30 DIM within all three parity groups 
were observed in cows which developed disease. For heifers, having a high prepartum NEFA 
value exacerbated this weight loss. Second lactation cows, having a high BHB reading within the 
first week following parturition was associated with accelerated weight loss.  For third lactation 
and greater cows, having a high postpartum NEFA value was associated with more rapid weight 
loss throughout the first 30 DIM. 
However, other metabolite readings and their association with the rate of weight loss is 
less clear.  For example, second lactation cows with normal prepartum NEFA levels and no 
disease lost weight more quickly than those which developed disease.  Another surprising result 
was that heifers and second-lactation cows with a high postpartum NEFA or high BHB levels 
and disease demonstrated the slowest rate of weight loss.  Heifers with disease but normal 
NEFA or BHB readings lost weight more quickly than their healthy peers.  Finally, third lactation 
and greater cows with both high prepartum NEFA values and disease lost weight more quickly 
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than healthy individuals, however, cows that experienced only one condition or the other 
demonstrated a reduced rate of weight loss.  Associations were inconsistent between calcium 
status and weight loss.  Occasionally the cows that experienced the most rapid weight loss were 
hypocalcemic and had disease, or had only one of these conditions.
Figure 9.  Average body weight in kilograms of the study population of 105 Holstein cows within 
the first 30 DIM, separated by parity and:
a   A prepartum NEFA of  > 0.3 mEq/dL and/or 
b   A postpartum NEFA of > 0.7 mEq/dL.
c   Any BHB reading of > 1.2 mmol/L.
d   Any calcium reading of > 6.0 mg/dL to 8.0 mg/dL.
Starting body weight and the slope of body weight was different among parity groups (p < 0.01).
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Parity Interaction Terms Estimate S.E. D.F. P-valueb
1st
Normal NEFA, no disease -2.0 0.1 1045 < 0.0001
Normal NEFA, disease -3.0 0.1 1045 < 0.0001
High NEFA, no disease -2.1 0.1 1045 < 0.0001
High NEFA, disease -2.5 0.1 1045 < 0.0001
2nd
Normal NEFA, no disease -3.5 c 0.2 866 < 0.0001
Normal NEFA, disease -2.8 0.2 866 < 0.0001
High NEFA, no disease -3.3 c 0.2 866 < 0.0001
High NEFA, disease . . . .
3rd+
Normal NEFA, no disease -1.7 0.1 1285 < 0.0001
Normal NEFA, disease -1.5 < 0.1 1285 < 0.0001
High NEFA, no disease -1.0 0.2 1285 < 0.0001
High NEFA, disease -2.9 0.1 1285 < 0.0001
Table 3A.  The Least Squares Means estimate of the interaction between prepartum NEFA of > 
0.3 mEq/dL and dichotomized diseasea on body weight change in 105 Holstein cows within the 
first 30 DIM, separated by parity.
a Diseases include clinical ketosis, displaced abomasum, lameness, clinical mastitis, retained 
placenta, and/or metritis.  Note that each condition is not mutually exclusive.
b The p-value from the Least Squares Means test evaluates whether the interaction estimate is 
different from zero.  This p-value is reported if all interaction combinations were populated.  If 
any interaction combinations were missing (indicated by point marks), the p-value for the Type 3 
Test of Mixed Effects, part of the PROC MIXED analysis, is reported.
c Estimates with the same superscript were not statistically different from each other (p > 0.05).
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Parity Interaction Terms Estimate S.E. D.F. P-valueb
1st
Normal NEFA, no disease -2.4 0.1 1045 < 0.0001
Normal NEFA, disease -3.2 0.1 1045 < 0.0001
High NEFA, no disease -2.1 0.1 1045 < 0.0001
High NEFA, disease -1.7 0.2 1045 < 0.0001
2nd
Normal NEFA, no disease -2.4 c 0.2 865 < 0.0001
Normal NEFA, disease -2.6 c 0.2 865 < 0.0001
High NEFA, no disease -3.4 0.2 865 < 0.0001
High NEFA, disease -2.0 0.2 865 < 0.0001
3rd+
Normal NEFA, no disease -1.7 d 0.1 1285 < 0.05
Normal NEFA, disease -1.9 d 0.1 1285 < 0.05
High NEFA, no disease -2.1 0.1 1285 < 0.05
High NEFA, disease -2.6 0.1 1285 < 0.05
Table 3B.  The Least Squares Means estimate of the interaction between postpartum NEFA of > 
0.7 mEq/dL and dichotomized diseasea on body weight change in 105 Holstein cows within the 
first 30 DIM, separated by parity.
a Diseases include clinical ketosis, displaced abomasum, lameness, clinical mastitis, retained 
placenta, and/or metritis.  Note that each condition is not mutually exclusive.
b The p-value from the Least Squares Means test evaluates whether the interaction estimate is 
different from zero.
c-d Estimates with the same superscript were not statistically different from each other (p > 0.05)
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Parity Interaction Terms Estimate S.E. D.F. P-value b
1st:
Sample 
1 or 2
Normal BHB, no disease -2.3 0.1 1046 < 0.0001
Normal BHB, disease -3.3 0.1 1046 < 0.0001
High BHB, no disease . . . .
High BHB, disease -1.9 0.1 1046 < 0.0001
2nd:
Sample 
1 or 2
Normal BHB, no disease -3.3 0.2 865 < 0.001
Normal BHB, disease -2.9 0.2 865 < 0.001
High BHB, no disease -3.8 0.2 865 < 0.001
High BHB, disease -2.6 0.2 865 < 0.001
3rd+:
Sample 
1 or 2
Normal BHB, no disease -1.6 c 0.1 1285 < 0.0001
Normal BHB, disease -1.4 d 0.1 1285 < 0.0001
High BHB, no disease -1.6 c,d 0.1 1285 < 0.0001
High BHB, disease -2.4 0.1 1285 < 0.0001
Table 3C.  The Least Squares Means estimate of the interaction between BHB of > 1.2 mmol/L 
and dichotomized diseasea on body weight change in 105 Holstein cows within the first 30 DIM, 
separated by parity.
a Diseases include clinical ketosis, displaced abomasum, lameness, clinical mastitis, retained 
placenta, and/or metritis.  Note that each condition is not mutually exclusive.
b The p-value from the Least Squares Means test evaluates whether the interaction estimate is 
different from zero.  This p-value is reported if all interaction combinations were populated.  If 
any interaction combinations were missing (indicated by point marks), the p-value for the Type 3 
Test of Mixed Effects, part of the PROC MIXED analysis, is reported.
c-d Estimates with the same superscript were not statistically different from each other (p > 0.05)
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Parity Interaction Terms Estimate S.E. D.F. P-value b
1st:
 Sample 2
Normal calcium, no disease -1.7 c 0.1 1045 < 0.0001
Normal calcium, disease -2.7 0.1 1045 < 0.0001
Hypocalcemic, no disease -3.2 0.1 1045 < 0.0001
Hypocalcemic, disease -1.8 c 0.1 1045 < 0.0001
2nd:
Any 
sample
Normal calcium, no disease -3.9 d 0.2 865 < 0.0001
Normal calcium, disease -4.6 0.2 865 < 0.0001
Hypocalcemic, no disease -3.8 d 0.2 865 < 0.0001
Hypocalcemic, disease -2.8 0.2 865 < 0.0001
3rd+:
Sample 2
Normal calcium, no disease -1.8 e,f 0.2 1285 < 0.005
Normal calcium, disease -1.7 e 0.1 1285 < 0.005
Hypocalcemic, no disease -2.0 f 0.1 1285 < 0.005
Hypocalcemic, disease -2.5 0.1 1285 < 0.005
Table 3D.  The Least Squares Means estimate of the interaction between calcium of > 0.6 to 0.8 
mg/dL and dichotomized diseasea on body weight change in 105 Holstein cows within the first 
30 DIM, separated by parity.
a Diseases include clinical ketosis, displaced abomasum, lameness, clinical mastitis, retained 
placenta, and/or metritis.  Note that each condition is not mutually exclusive.
b The p-value from the Least Squares Means test evaluates whether the interaction estimate is 
different from zero.
c-f Estimates with the same superscript were not statistically different from each other (p > 0.05)
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Associations: Milk Yield
There was no statistically significant difference between milk production in the 2nd and ≥ 
3rd lactation (p > 0.05), as shown in Figure 10.  However, there was a significant difference in 
milk production between 1st lactation and ≥ 2nd lactation cows (p < 0.01).  Therefore, the milk 
production analysis was stratified by parity in two groups (parity = 1 and parity ≥ 2).  Tables 
4A-4D show the effect of total milk production within 30 DIM based on the interaction between 
normal or abnormal values for each indicator metabolite and the presence or absence of disease: 
prepartum NEFA (4A), postpartum NEFA (4B), BHB (4C) and calcium (4D).  When an 
interaction term was included, the effect of only the blood metabolite or disease occurrence could 
not be evaluated individually because the result depends on the values of both terms in the 
interaction.  Therefore, the interaction estimates and p-values are reported.
Heifers with elevated prepartum NEFA readings had the highest milk yield, a result that 
was not expected.  Prepartum NEFA otherwise impacted lactation as expected: both disease and a 
high NEFA value were independently associated with a decreased milk yield, but the greatest 
loss in milk yield occurred in cows that experienced both conditions.
Cows within all parity groups that presented with high postpartum NEFA readings and 
disease during the course of the study had the lowest milk yield, while second and greater 
lactation cows that were unaffected with either condition had the highest yield.  However, the 
impact of either elevated prepartum NEFA or disease alone, generated statistically similar, slight 
reductions in milk yield.
Sampling BHBs both day three and five and looking at the presence of disease was useful 
in predicting milk yield in second lactation and greater cows.  As shown in Table 4C, if sampling 
resources are limited, little of that resolution is lost by only sampling on day three.
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Normocalcemic second and greater lactation cows had the highest milk yield.  
Unexpectedly, hypocalcemic heifers produced substantially more milk compared to those with 
normal calcium values.  Excluding this anomaly, both sub-clinical hypocalcemia and disease 
reduced milk production in all cows in the study, but the combination was more potent.
Figure 10.  Average daily milk yield in kilograms of the study population of 105 Holstein cows 
within the first 30 DIM, separated by parity and:
a   A prepartum NEFA of  > 0.3 mEq/dL and/or 
b   A postpartum NEFA of > 0.7 mEq/dL.
c   Any BHB reading of > 1.2 mmol/L.
d   Any calcium reading of > 6.0 mg/dL to 8.0 mg/dL.
There was no significant difference in milk yield between parity groups 2 and > 3 (p > 0.05), but 
there was a difference between parity groups 1 and > 2 (p < 0.01).  
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Parity Interaction Terms Estimate S.E. D.F. P-valueb
1st
Normal NEFA, no disease 972 c 18.5 1045 < 0.0001
Normal NEFA, disease 954 c,d 19.4 1045 < 0.0001
High NEFA, no disease 1056 17.8 1045 < 0.0001
High NEFA, disease 938 d 20.2 1045 < 0.0001
2nd+
Normal NEFA, no disease 1229 15.7 2155 < 0.05
Normal NEFA, disease 1128 e 15.6 2155 < 0.05
High NEFA, no disease 1113 e 19.1 2155 < 0.05
High NEFA, disease 1063 17.9 2155 < 0.05
Table 4A.  The Least Squares Means estimate of the interaction between prepartum NEFA of > 
0.3 mEq/dL and dichotomized diseasea on total milk yield in 105 Holstein cows within the first 
30 DIM, separated by parity.
a Diseases include clinical ketosis, displaced abomasum, lameness, clinical mastitis, retained 
placenta, and/or metritis.  Note that each condition is not mutually exclusive.
b The p-value from the Least Squares Means test evaluates whether the interaction estimate is 
different from zero.
c-e Estimates with the same superscript were not statistically different from each other (p > 0.05)
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Parity Interaction Terms Estimate S.E. D.F. P-value b
1st
Normal NEFA, no disease 1064 19.1 1045 0.6
Normal NEFA, disease 994 c 19.5 1045 0.6
High NEFA, no disease 992 c 20.0 1045 0.6
High NEFA, disease 906 30.0 1045 0.6
2nd+
Normal NEFA, no disease 1205 18.3 2155 0.5
Normal NEFA, disease 1113 d 17.0 2155 0.5
High NEFA, no disease 1127 d 17.6 2155 0.5
High NEFA, disease 1050 18.9 2155 0.5
Table 4B.  The Least Squares Means estimate of the interaction between postpartum NEFA of > 
0.7 mEq/dL and dichotomized diseasea on total milk yield in 105 Holstein cows within the first 
30 DIM, separated by parity.
a Diseases include clinical ketosis, displaced abomasum, lameness, clinical mastitis, retained 
placenta, and/or metritis.  Note that each condition is not mutually exclusive.
b The p-value from the Least Squares Means test evaluates whether the interaction estimate is 
different from zero.
c-d Estimates with the same superscript were not statistically different from each other (p > 0.05)
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Parity Interaction Terms Estimate S.E. D.F. P-valueb
1st:
Sample 
1 or 2
Normal BHB, no disease 1033 18.0 1046 < 0.0001
Normal BHB, disease 983 19.7 1046 < 0.0001
High BHB, no disease . . . .
High BHB, disease 916 23.4 1046 < 0.0001
2nd+:
Sample 
1 only
Normal BHB, no disease 1262 7.1 2155 < 0.0001
Normal BHB, disease 1144 6.6 2155 < 0.0001
High BHB, no disease 899 21.2 2155 < 0.0001
High BHB, disease 1116 11.1 2155 < 0.0001
2nd+:
Sample 
1 or 2
Normal BHB, no disease 1243 14.3 2155 < 0.0001
Normal BHB, disease 1127 c 15.2 2155 < 0.0001
High BHB, no disease 1067 19.1 2155 < 0.0001
High BHB, disease 1120 c 14.1 2155 < 0.0001
Table 4C.  The Least Squares Means estimate of the interaction between BHB of > 1.2 mmol/L 
and dichotomized diseasea on total milk yield in 105 Holstein cows within the first 30 DIM, 
separated by parity.
a Diseases include clinical ketosis, displaced abomasum, lameness, clinical mastitis, retained 
placenta, and/or metritis.  Note that each condition is not mutually exclusive.
b The p-value from the Least Squares Means test evaluates whether the interaction estimate is 
different from zero.  This p-value is reported if all interaction combinations were populated.  If 
any interaction combinations were missing (indicated by point marks), the p-value for the Type 3 
Test of Mixed Effects, part of the PROC MIXED analysis, is reported.
c Estimates with the same superscript were not statistically different from each other (p > 0.05).
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Parity Interaction Terms Estimate S.E. D.F. P-value b
1st:
Any 
sample
Normal calcium, no disease 954 c 16.9 1045 < 0.0001
Normal calcium, disease 953 c 17.1 1045 < 0.0001
Hypocalcemic, no disease 1119 17.6 1045 < 0.0001
Hypocalcemic, disease 889 23.2 1045 < 0.0001
2nd+:
Sample 
3 only
Normal calcium, no disease 1206 17.0 2155 < 0.0001
Normal calcium, disease 1086 d,e 17.0 2155 < 0.0001
Hypocalcemic, no disease 1100 d,f 19.3 2155 < 0.0001
Hypocalcemic, disease 1078 e,f 18.2 2155 < 0.0001
Table 4D.  The Least Squares Means estimate of the interaction between calcium of > 6.0 to 8.0 
mg/dL and dichotomized diseasea on total milk yield in 105 Holstein cows within the first 30 
DIM, separated by parity.
a Diseases include clinical ketosis, displaced abomasum, lameness, clinical mastitis, retained 
placenta, and/or metritis.  Note that each condition is not mutually exclusive.
b The p-value from the Least Squares Means test evaluates whether the interaction estimate is 
different from zero.
c-f Estimates with the same superscript were not statistically different from each other (p > 0.05)
41
Discussion
 A practical goal of this research is to reliably identify early warning signs that a cow is at 
high risk of experiencing a precipitous loss in body weight and/or milk yield, so that therapeutic 
intervention can be administered.  Negative energy balance and sub-clinical hypocalcemia are of 
interest because of their implications for economic return and animal welfare.  They are of 
particular interest in the manifestation of and interactions with disease, because health problems 
tend to occur not in isolation, but as part of a physiological complex (Fleischer et al., 2001; Lean, 
2011).   Metabolic indicators such as NEFA, BHB, and calcium measurements are useful for 
monitoring the cow’s current homeorhetic status, and in some cases are also associated with the 
development of disease (DeGaris and Lean, 2008; McArt et al., 2013; Suthar et al., 2013).  
Disease has an important impact on overall bovine health and consequential economic return 
(Duffield et al., 2009; Mulligan and Doherty, 2008; Rajala-Schultz et al., 1999; 
Thirunavukkarasu et al., 2010).  In this study, measurements were made early in the postpartum 
period on transition period cows to find the best predictive blood metabolite criteria that was 
associated with body weight change and milk yield with disease as a covariate and while 
controlling for herd as a random effect.  
 Cows from all three parity groups which developed disease had a higher rate of weight 
loss and lower milk yield during the first 30 DIM.  Third and greater parity cows experienced an 
overall higher disease incidence than second or lower parity cows, a finding supported by 
previous studies (Gallo et al., 1996; Lean, 2011; McArt et al., 2013; Reinhardt et al., 2011).  
Among these conditions, lameness and ketosis were the most prevalent diseases experienced by 
second and third and greater lactation cows, while metritis was the most common disorder 
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experienced by heifers. All heifers with high BHB readings at three and five DIM were 
developed disease, as did all second lactation cows with high prepartum NEFA.  In future work, 
disease development itself could be analyzed as an undesirable outcome, rather than simply as a 
predictor.
 In each parity group, a different indicator metabolite predicted rate of weight change: 
prepartum NEFA was the best predictor for heifers, a high day three or day five BHB reading 
was predictive for second lactation cows, and postpartum NEFA values were most useful for 
third and greater lactation cows.  Calcium was not a reliable indicator for a cow’s change in body  
weight for the first 30 DIM for any lactation group.  
 Prepartum NEFA and day three and day five BHB measurements were reliable indicators 
of milk yield in second lactation and greater cows.  For heifers, abnormal metabolite values 
significantly impacted milk yield when it was concurrent with disease.  One unusual finding was 
that heifers with high prepartum NEFA values or sub-clinical hypocalcemia which did not 
develop disease produced significantly more milk than their unaffected herd mates.  Chapinal et 
al. (2012) discovered that cows with high prepartum NEFA and low calcium values had a 
reduced milk yield.  However, Østergaard and Larsen (2000) found that sub-clinical 
hypocalcemia at calving does not affect milk yield, and Jawor et al. (2012) reported that cows 
with sub-clinical hypocalcemia actually produced more milk, although only third and greater 
parity cows sustained this higher yield through 280 DIM and this result was presented without 
the effects of disease.
 From the perspective of input costs, BHB is the least expensive test to run at only $1.30 
compared to the cost of calcium at $8.00 and NEFA at $11.00, but these costs are almost 
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negligible when these prices are put into the perspective of risking disease and a loss in milk 
production due to negative energy balance and sub-clinical hypocalcemia.  As a review of 
relevant literature has revealed, disease development can cost a farmer up to hundreds of dollars 
from a single cow, a price which reflects the cost of medical treatment, lost milk production, and 
in bringing the cow back to a healthy status or replacing it if it has to be culled.  As demonstrated 
in this study, these metabolites and disease can affect a cow’s milk yield during the first 30 DIM.  
Even if affected cows only lose 100 kg of milk during the transition period, United States 
Department of Agriculture statistics indicate a converted market price of approximately $44 
(USDA, 2013), which is significant if multiple cows are affected as they were in this study.
 In this study, back fat and body condition score were only weakly correlated with one 
another.  Without the ability to rank the validity of one measurement over the other, neither was 
analyzed as an outcome.  However, as they could be indicators of disease development in dairy 
cattle (Lassen et al., 2003; Roche et al., 2009), these are measurements of interest.  Future studies 
could determine how these measurements are correlated with the cow’s overall body weight and 
their association with blood metabolites, milk yield, and disease.
 The greatest limiting factor of this study was the size of the sample population.  There 
were not enough cows to represent every possible interaction between normal versus deviant 
blood metabolite levels and presence of disease to comprehensively analyze their relationships 
with rate of weight loss and milk production.  While this is indicative of good animal health and 
management on the participant farms in this study, it limited our statistical analyses.
 In light of these results, a useful management strategy for minimizing the rate of weight 
loss and maximizing milk yield during the first 30 DIM is to conduct different metabolite tests 
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for cows depending on their parity, and to remain vigilant in observing cows for potential disease 
development.  As previously mentioned, there are outside costs and minor labor inconveniences 
in collecting samples for testing.  However, if high risk cows can be identified early during the 
lactation period, intervention can be initiated to maintain energy balance and calcium 
homeostasis, and assist in the prevention of disease.  By maximizing individual cow health, the 
dairy producer benefits financially and optimizes the health and welfare of the herd as a whole.
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Conclusion
 The objectives in this study were to help identify high risk cows, explain which factors 
predispose them to negative outcomes, and make economically sound, practical 
recommendations for farmers to improve herd monitoring and management.  Through the 
analysis of blood metabolite tests and disease and their impact on rate of weight loss and milk 
yield, certain metabolites were recognized as reliable indicators depending on the outcome of 
interest, the cow’s parity, and whether abnormal metabolite readings coincided with the 
development of disease during the first 30 DIM.
 A dairy producer can use measurements of prepartum or day five NEFA, and day three 
and day five BHB to screen cows according to parity and whether the outcome of interest for that 
cow is change in body weight or milk yield during the first 30 DIM.  Serum calcium levels are 
not reliable predictors of a change in body weight, and only affect milk yield when sub-clinical 
hypocalcemia occurs simultaneously with disease.  By identifying high-risk cows, early 
intervention protocols can prevent the loss of milk, minimize animal welfare concerns, and 
maximize economic sustainability for the dairy producer.
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